Trials / Completed
CompletedNCT06606184
Benefits of Pulmonary Rehabilitation to Patients Post Liver Transplant
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 78 (actual)
- Sponsor
- Chang Gung University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial was to access the benefits of a 12-week home-based pulmonary rehabilitation regimen on pulmonary function recovery in post-liver transplant patients. The main questions it aims to answer are: Does pulmonary rehabilitation facilitate pulmonary muscle strength recovery? Does the intervention improve pulmonary function and reduce dyspnea sensation? Participants performed: Inspiratory muscle training twice a day for 12 weeks after discharged from the hospital Upper limb resistive training Lower limb exercise
Detailed description
Patients undergoing liver transplantation often face significant challenges related to pulmonary rehabilitation. Although postoperative rehabilitation has been extensively studied, the specific role of pulmonary rehabilitation programs has received limited attention. This study aims to evaluate the efficacy of a home-based pulmonary rehabilitation program in improving respiratory function recovery among post-liver transplant patients. The training group participated in a 12-week pulmonary rehabilitation program post-discharge, emphasizing respiratory muscle and exercise training, while the control group received standard care, which included traditional rehabilitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Inspiratory muscle Training | Participants underwent a 12-week program consisting of inspiratory muscle training twice daily, incentive spirometry three times daily, and upper limb exercises along with marching in place for 30 minutes. |
| PROCEDURE | Routine Care | Participants received routine care, which included encouragement to use incentive spirometry three times daily. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2024-09-20
- Last updated
- 2024-09-20
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT06606184. Inclusion in this directory is not an endorsement.